Quick Takeaways
- Jeffrey C. Pepe has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $197,938.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jeffrey C. Pepe
- Location
- Seattle, WA
- Summary
- The estimated net worth of Jeffrey C. Pepe is at least $197,938 dollars as of 08 Sep 2022. Jeffrey C. Pepe is the Interim CEO and GC of Silverback Therapeutics, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $197.9K.
- Signature
- /s/ Jeffrey C. Pepe
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jeffrey C. Pepe and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Silverback Therapeutics, Inc. ($197,938).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jeffrey C. Pepe
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRY | Silverback Therapeutics, Inc. | Interim CEO and GC | $197,938 | 02 Sep 2022 |
Insider Transactions Reported by Jeffrey C. Pepe:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.